Increased Susceptibility to Experimental Autoimmune Neuritis after Upregulation of the Autoreactive T Cell Response to Peripheral Myelin Antigen in Apolipoprotein E-Deficient Mice

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 2, 2004, Pages 120-128

  Yu, Shuo ^a   Duan, Rui Sheng ^a   Chen, Zhiguo ^a   Quezada, Hernan Concha ^a   Bao, Lei ^a   Nennesmo, Inger ^a   Zhu, Shun Wei ^a   Winblad, Bengt ^a   Ljunggren, Hans Gustaf ^a   Zhu, Jie ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b JILIN UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Cytokines; Experimental autoimmune neuritis (EAN); Guillain Barr syndrome; Th1 Th2

Indexed keywords

APOLIPOPROTEIN E; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MYELIN; MYELIN PROTEIN; MYELIN PROTEIN[180-199]; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DEMYELINATION; DISEASE PREDISPOSITION; EXPERIMENTAL AUTOIMMUNE NEURITIS; GUILLAIN BARRE SYNDROME; IMMUNE RESPONSE; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MACROPHAGE FUNCTION; MALE; MOUSE; NEURITIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 10744228867     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.2.120     Document Type: Article

References (53)

1. Deretzi G, Zou LP, Pelidou SH, et al. Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination. J Autoimmun 1999;12:81-89
2. Shin HC, McFarlane EF, Pollard JD, Watson EG. Induction of experimental allergic neuritis with synthetic peptides from myelin P2 protein. Neurosci Lett 1989;102:309-12
3. Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome. J Neuroimmunol 1998;84:40-52
4. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 1984;133:1946-50
5. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: Induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 1992;22:1813-17
6. Rostami A, Burns JB, Brown MJ, et al. Transfer of experimental allergic neuritis with P2-reactive T-cell lines. Cell Immunol 1985;91:354-61
7. Zhu J, Nennesmo I, Deng GM, et al. Induction of experimental autoimmune neuritis in CD4-8-C57BL/6J mice. J Neuroimmunol 1999;94:196-203
8. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30
9. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997;99:2752-61
10. Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001;104:197-202
11. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995;92:8264-68
12. Zhou X, Nicoletti A, Elhage R, Hansson GK. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000;102:2919-22
13. Aisen PS. Inflammation and Alzheimer disease. Mol Chem Neuropathol 1996;28:83-88
14. Guo Z, Fratiglioni L, Viitanen M, et al. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication? Am J Epidemiol 2001;153:225-31
15. Laskowitz DT, Lee DM, Schmechel D, Staats HF. Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 2000;41:613-20
16. Avila EM, Holdsworth G, Sasaki N, Jackson RL, Harmony JA. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J Biol Chem 1982;257:5900-5909
17. Macy M, Okano Y, Cardin AD, Avila EM, Harmony JA. Suppression of lymphocyte activation by plasma lipoproteins. Cancer Res 1983;43:2496s-2502s
18. Grocott HP, Newman MF, El-Moalem H, Bainbridge D, Butler A, Laskowitz DT. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg 2001;122:622-23
19. Chapman J, Sylantiev C, Nisipeanu P, Korczyn AD. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis. Arch Neurol 1999;56:1484-87
20. Chapman J, Vinokurov S, Achiron A, et al. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 2001;56:312-16
21. Sylantiev C, Chapman J, Chilkevich O, Nisipeanu P, Chistik V, Korczyn A. The APOE 4 allele and progression of disability in multiple sclerosis. Neurology 1998;50:P03060 Suppl
22. Karussis D, Michaelson D, Abramsky O, Korczyn A, Mizrachi-Koll R, Chapman Y. Increased susceptibility to experimental autoimmune encephalomyelitis (EAE) in apoE-knockout mice. Neurology 1999;52:A339 Suppl
23. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-53
24. Dyer CA, Smith RS, Curtiss LK. Only multimers of a synthetic peptide of human apolipoprotein E are biologically active. J Biol Chem 1991;266:15009-15
25. Kelly ME, Clay MA, Mistry MJ, Hsieh-Li HM, Harmony JA. Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: Production of interleukin 2 with reduced biological activity. Cell Immunol 1994;159:124-39
26. Mistry MJ, Clay MA, Kelly ME, Steiner MA, Harmony JA. Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary. Cell Immunol 1995;160:14-23
27. Han SH, Chung SY. Marked hippocampal neuronal damage without motor deficits after mild concussive-like brain injury in apolipoprotein E-deficient mice. Ann N Y Acad Sci 2000;903:357-65
28. de Bont N, Netea MG, Demacker PN, Kullberg BJ, van der Meer JW, Stalenhoef AF. Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest 2000;30:818-22
29. Ludewig B, Jaggi M, Dumrese T, et al. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses. J Immunol 2001;166:3369-76
30. Roselaar SE, Daugherty A. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 1998;39:1740-43
31. Jung S, Huitinga I, Schmidt B, et al. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis. J Neurol Sci 1993;119:195-202
32. Kiefer R, Kieseier BC, Stoll G, Hartung HP. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 2001;64:109-27
33. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995;144:245-68
34. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263-66
35. Fujioka T, Jimi T, Hilliard BA, Ventura ES, Rostami A. The expression of cytokine mRNA in the cauda equina of Lewis rats with experimental allergic neuritis. J Neuroimmunol 1998;84:223-29
36. Zhu J, Bai XF, Mix E, Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin Immunol Immunopathol 1997;84:85-94
37. Zhu J, Bai XF, Mix E, Link H. Experimental allergic neuritis: Cytolysin mRNA expression is upregulated in lymph node cells during convalescence. J Neuroimmunol 1997;78:108-16
38. Pelidou SH, Zou LP, Deretzi G, et al. Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats. Scand J Immunol 2000;51:29-35
39. Zhu J, Link H, Mix E, Olsson T, Huang WX. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol Scand 1994;90:19-25
40. Zhu Y, Ljunggren HG, Mix E, et al. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice. Exp Neurol 2001;169:472-78
41. Furlan R, Brambilla E, Ruffini F, et al. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol 2001;167:1821-29
42. Furlan R, Bergami A, Cantarella D, et al. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: Critical roles for administration route and IFN-gamma. Eur J Immunol 2003;33:1830-38
43. Bai XE Zhu J, Zhang GX, et al. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clin Immunol Immunopathol 1997;83:117-26
44. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 1998;161:3299-3306
45. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003;55:241-69
46. Fullerton SM, Shirman GA, Strittmatter WJ, Matthew WD. Impairment of the blood-nerve and blood-brain barriers in apolipoprotein E knockout mice. Exp Neurol 2001;169:13-22
47. Pan W, Kastin AJ. Changing the chemokine gradient: CINC1 crosses the blood-brain barrier. J Neuroimmunol 2001;115:64-70
48. Zou LP, Pelidou SH, Abbas N, et al. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol 1999;98:168-75
49. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-31
50. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45
51. Tran EH, Prince EN, Owens T. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol 2000;164:2759-68
52. Noelle RJ, Snow EC. Cognate interactions between helper T cells and B cells. Immunol Today 1990;11:361-68
53. Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000;6:88-91